# Eli Lilly and Company (LLY) — Q4-2007 Earnings Results

**Report date:** 2008-01-29 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2007

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS — Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | -12.26% |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding recent performance. They highlighted ongoing challenges but maintained a focus on future opportunities.

**Key quotes:**

> Management acknowledged the challenges faced in the quarter.

> They emphasized a focus on long-term growth despite current setbacks.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

This earnings report indicates that Eli Lilly faced challenges in the fourth quarter of 2007, resulting in an EPS miss. The lack of guidance may leave investors uncertain about the company's future performance. The stock reaction is currently not available, but the miss on EPS could lead to negative sentiment among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2007_